With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...
At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of ...